Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 12

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

From One-Cell to Tissue: Reprogramming, Cell Differentiation and Tissue Engineering

Zhang, Donghui, Jiang, Wei·2015·BioScience
DOI 10.1093/biosci/biv016
Open this paper in CoChat — free account

Abstract

Adult somatic cells can be reprogrammed into pluripotent stem cells, which can indefinitely proliferate in a dish and differentiate into almost all the cell types that constitute the human body. These cells hold great promise for cell therapy and regenerative medicine, as well as drug screening and disease modeling. Theoretically, we can create a source of versatile, therapeutic cells that could be genetically matched to any patient. These pluripotent stem cells can be differentiated into desired cell types and eventually used to reconstruct a tissue or an organ with insights gained from tissue engineering. Inspired by the pioneering work in stem cells, particularly the remarkable reprogramming technique, the fields of regenerative medicine and tissue engineering have advanced rapidly in the past several years. Here recent progress in the fields of induced pluripotent stem cells and tissue engineering is reviewed, with a focus on applications in medicine.

Overview

Integrity signals

Registry

Crossref · 10.1093/biosci/biv016

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 5 references

Research works printed but not linked: 64

  1. Badylak, 2011, Whole-organ tissue engineering: Decellularization and recellularization of three-dimensional matrix scaffolds, Annual Review of Biomedical Engineering, 13, 27, 10.1146/annurev-bioeng-071910-124743 · DOI · Paper page
  2. Cheng, 2012, Self-renewing endodermal progenitor lines generated from human pluripotent stem cells, Cell Stem Cell, 10, 371, 10.1016/j.stem.2012.02.024 · DOI
  3. Chong, 2014, Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts, Nature, 510, 273, 10.1038/nature13233 · DOI
  4. Chung, 2014, Human somatic cell nuclear transfer using adult cells, Cell Stem Cell, 14, 777, 10.1016/j.stem.2014.03.015 · DOI
  5. Delatte, 2001, Effectiveness of beta-glucan collagen for treatment of partial-thickness burns in children, Journal of Pediatric Surgery, 36, 113, 10.1053/jpsu.2001.20024 · DOI
  6. Drury, 2003, Hydrogels for tissue engineering: scaffold design variables and applications, Biomaterials, 24, 4337, 10.1016/S0142-9612(03)00340-5 · DOI · Paper page
  7. Dubois, 2011, SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells, Nature Biotechnology, 29, 1011, 10.1038/nbt.2005 · DOI
  8. Engelmayr, 2008, Accordion-like honeycombs for tissue engineering of cardiac anisotropy, Nature Materials, 7, 1003, 10.1038/nmat2316 · DOI · Paper page
  9. Engler, 2006, Matrix elasticity directs stem cell lineage specification, Cell, 126, 677, 10.1016/j.cell.2006.06.044 · DOI · Paper page
  10. Flanagan, 2006, A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications, Biomaterials, 27, 2233, 10.1016/j.biomaterials.2005.10.031 · DOI
  11. Gilbert, 2006, Decellularization of tissues and organs, Biomaterials, 27, 3675
  12. Gonzalez, 2011, Methods for making induced pluripotent stem cells: Reprogramming a la carte, Nature Reviews Genetics, 12, 231, 10.1038/nrg2937 · DOI
  13. Graf, 2011, Historical origins of transdifferentiation and reprogramming, Cell Stem Cell, 9, 504, 10.1016/j.stem.2011.11.012 · DOI · Paper page
  14. Grskovic, 2011, Induced pluripotent stem cells: Opportunities for disease modelling and drug discovery, Nature Reviews Drug Discovery, 10, 915, 10.1038/nrd3577 · DOI
  15. Gu, 2011, Construction of tissue engineered nerve grafts and their application in peripheral nerve regeneration, Progress in Neurobiology, 93, 204, 10.1016/j.pneurobio.2010.11.002 · DOI
  16. Han, 2010, Induced pluripotent stem cells: The dragon awakens, BioScience, 60, 278, 10.1525/bio.2010.60.4.6 · DOI
  17. Hirata, 2014, A chemical probe that labels human pluripotent stem cells, Cell Reports, 6, 1165, 10.1016/j.celrep.2014.02.006 · DOI
  18. Hou, 2013, Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds, Science, 341, 651, 10.1126/science.1239278 · DOI · Paper page
  19. Itskovitz-Eldor, 2000, Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers, Molecular Medicine, 6, 88, 10.1007/BF03401776 · DOI
  20. Jamaladdin, 2014, Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells, Proceedings of the National Academy of Sciences, 111, 9840, 10.1073/pnas.1321330111 · DOI
  21. Jiang, 2011, CD24: a novel surface marker for PDX1-positive pancreatic progenitors derived from human embryonic stem cells, Stem Cells, 29, 609, 10.1002/stem.608 · DOI
  22. Jiang, 2013, WNT3 is a biomarker capable of predicting the definitive endoderm differentiation potential of hESCs, Stem Cell Reports, 1, 46, 10.1016/j.stemcr.2013.03.003 · DOI
  23. Johannesson, 2014, Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors, Cell Stem Cell, 15, 634, 10.1016/j.stem.2014.10.002 · DOI
  24. Kamao, 2014, Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application, Stem Cell Reports, 2, 205, 10.1016/j.stemcr.2013.12.007 · DOI · Paper page
  25. Kelly, 2011, Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells, Nature Biotechnology, 29, 750, 10.1038/nbt.1931 · DOI · Paper page
  26. Khetani, 2008, Microscale culture of human liver cells for drug development, Nature Biotechnology, 26, 120, 10.1038/nbt1361 · DOI · Paper page
  27. Kilian, 2010, Geometric cues for directing the differentiation of mesenchymal stem cells, Proceedings of the National Academy of Sciences, 107, 4872, 10.1073/pnas.0903269107 · DOI · Paper page
  28. Kim, 2011, miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells, Cell Stem Cell, 8, 695, 10.1016/j.stem.2011.04.002 · DOI
  29. Kim, 2009, Direct reprogramming of human neural stem cells by OCT4, Nature, 461, 649, 10.1038/nature08436 · DOI · Paper page
  30. Kuo, 2014, Selective elimination of human pluripotent stem cells by a marine natural product derivative, Journal of the American Chemical Society, 136, 9798, 10.1021/ja501795c · DOI
  31. Lancaster, 2014, Organogenesis in a dish: Modeling development and disease using organoid technologies, Science, 345, 1247125, 10.1126/science.1247125 · DOI · Paper page
  32. Lancaster, 2013, Cerebral organoids model human brain development and microcephaly, Nature, 501, 373, 10.1038/nature12517 · DOI · Paper page
  33. Langer, 1993, Tissue engineering, Science, 260, 920, 10.1126/science.8493529 · DOI · Paper page
  34. Lee, 2013, Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies, Nature Medicine, 19, 998, 10.1038/nm.3267 · DOI
  35. Liu, 2008, Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts, Cell Stem Cell, 3, 587, 10.1016/j.stem.2008.10.014 · DOI
  36. Ma, 2014, Abnormalities in human pluripotent cells due to reprogramming mechanisms, Nature, 511, 177, 10.1038/nature13551 · DOI · Paper page
  37. McCain, 2014, Matrix elasticity regulates the optimal cardiac myocyte shape for contractility, American Journal of Physiology Heart and Circulatory Physiology, 306, H1525, 10.1152/ajpheart.00799.2013 · DOI
  38. Mummery, 2003, Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells, Circulation, 107, 2733, 10.1161/01.CIR.0000068356.38592.68 · DOI · Paper page
  39. Murry, 2008, Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development, Cell, 132, 661, 10.1016/j.cell.2008.02.008 · DOI
  40. Nunes, 2013, Biowire: A platform for maturation of human pluripotent stem cell-derived cardiomyocytes, Nature Methods, 10, 781, 10.1038/nmeth.2524 · DOI · Paper page
  41. O'Brien, 2005, The effect of pore size on cell adhesion in collagen-GAG scaffolds, Biomaterials, 26, 433, 10.1016/j.biomaterials.2004.02.052 · DOI
  42. Oh, 2013, Hydrophilization of synthetic biodegradable polymer scaffolds for improved cell/tissue compatibility, Biomedical Materials, 8, 10.1088/1748-6041/8/1/014101 · DOI
  43. Osafune, 2008, Marked differences in differentiation propensity among human embryonic stem cell lines, Nature Biotechnology, 26, 313, 10.1038/nbt1383 · DOI · Paper page
  44. Ott, 2008, Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart, Nature Medicine, 14, 213, 10.1038/nm1684 · DOI · Paper page
  45. Ott, 2010, Regeneration and orthotopic transplantation of a bioartificial lung, Nature Medicine, 16, 927, 10.1038/nm.2193 · DOI · Paper page
  46. Park, 2008, Disease-specific induced pluripotent stem cells, Cell, 134, 877, 10.1016/j.cell.2008.07.041 · DOI · Paper page
  47. Rezania, 2014, Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells, Nature Biotechnology, 32, 1121, 10.1038/nbt.3033 · DOI · Paper page
  48. Schulz, 2012, A scalable system for production of functional pancreatic progenitors from human embryonic stem cells, PLOS ONE, 7, 10.1371/journal.pone.0037004 · DOI · Paper page
  49. Sneddon, 2012, Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme, Nature, 491, 765, 10.1038/nature11463 · DOI
  50. Song, 2013, Regeneration and experimental orthotopic transplantation of a bioengineered kidney, Nature Medicine, 19, 646, 10.1038/nm.3154 · DOI · Paper page
  51. Spence, 2011, Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro, Nature, 470, 105, 10.1038/nature09691 · DOI · Paper page
  52. Stevens, 2013, InVERT molding for scalable control of tissue microarchitecture, Nature Communications, 4, 1847, 10.1038/ncomms2853 · DOI
  53. Tachibana, 2013, Human embryonic stem cells derived by somatic cell nuclear transfer, Cell, 153, 1228, 10.1016/j.cell.2013.05.006 · DOI
  54. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  55. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  56. Takebe, 2013, Vascularized and functional human liver from an iPSC-derived organ bud transplant, Nature, 499, 481, 10.1038/nature12271 · DOI · Paper page
  57. Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 · DOI · Paper page
  58. Uygun, 2010, Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix, Nature Medicine, 16, 814, 10.1038/nm.2170 · DOI · Paper page
  59. Warren, 2010, Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA, Cell Stem Cell, 7, 618, 10.1016/j.stem.2010.08.012 · DOI · Paper page
  60. Williams, 2012, SnapShot: Directed differentiation of pluripotent stem cells, Cell, 149, 1174, 10.1016/j.cell.2012.05.015 · DOI
  61. Yamada, 2014, Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells, Nature, 510, 533, 10.1038/nature13287 · DOI
  62. Zhang, 2013, Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes, Biomaterials, 34, 5813, 10.1016/j.biomaterials.2013.04.026 · DOI · Paper page
  63. Zhao, 2011, Immunogenicity of induced pluripotent stem cells, Nature, 474, 212, 10.1038/nature10135 · DOI · Paper page
  64. Zimmermann, 2002, Tissue engineering of a differentiated cardiac muscle construct, Circulation Research, 90, 223, 10.1161/hh0202.103644 · DOI · Paper page

Cited by

Metadata

Authors
Zhang, D., & Jiang, W.
Venue
BioScience
Publisher
Oxford University Press (OUP)
Published
2015-02-28
Volume
65
Issue
5
Pages
468-475
ISSN
  • 1525-3244
  • 0006-3568
DOI
10.1093/biosci/biv016
Cited by
12
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.